{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T04:24:58Z","timestamp":1684643098872},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T00:00:00Z","timestamp":1549670400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1038\/s41390-019-0309-8","type":"journal-article","created":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T14:09:23Z","timestamp":1549721363000},"page":"1032-1040","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Postnatal outcomes in lambs exposed antenatally and acutely postnatally to fluoxetine"],"prefix":"10.1038","volume":"85","author":[{"given":"Tuan Anh","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne","family":"Riggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Rurak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,9]]},"reference":[{"key":"309_CR1","doi-asserted-by":"publisher","first-page":"194.e1","DOI":"10.1016\/j.ajog.2007.07.036","volume":"198","author":"SE Andrade","year":"2008","unstructured":"Andrade, S. E. et al. Use of antidepressant medications during pregnancy: a multisite study. Am. J. Obstet. Gynecol. 198, 194.e1\u2013194.e5 (2008).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"309_CR2","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1001\/archpsyc.63.8.898","volume":"63","author":"TF Oberlander","year":"2006","unstructured":"Oberlander, T. F., Warburton, W., Misri, S., Aghajanian, J. & Hertzman, C. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch. Gen. Psychiatry 63, 898\u2013906 (2006).","journal-title":"Arch. Gen. Psychiatry"},{"key":"309_CR3","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1001\/jama.293.19.2372","volume":"293","author":"EL Moses-Kolko","year":"2005","unstructured":"Moses-Kolko, E. L. et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 293, 2372\u20132383 (2005).","journal-title":"JAMA"},{"key":"309_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1017\/neu.2016.30","volume":"29","author":"N Kieviet","year":"2017","unstructured":"Kieviet, N. et al. Serotonin and poor neonatal adaptation after antidepressant exposure in utero. Acta Neuropsychiatr. 29, 43\u201353 (2017).","journal-title":"Acta Neuropsychiatr."},{"key":"309_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1001\/archpedi.160.2.173","volume":"160","author":"R Levinson-Castiel","year":"2006","unstructured":"Levinson-Castiel, R., Merlob, P., Linder, N., Sirota, L. & Klinger, G. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch. Pediatr. Adolesc. Med. 160, 173\u2013176 (2006).","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"309_CR6","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/apa.12921","volume":"104","author":"N Kieviet","year":"2015","unstructured":"Kieviet, N. et al. Risk factors for poor neonatal adaptation after exposure to antidepressants in utero. Acta Paediatr. 104, 384\u2013391 (2015).","journal-title":"Acta Paediatr."},{"key":"309_CR7","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1071\/RD05030","volume":"17","author":"JL Morrison","year":"2005","unstructured":"Morrison, J. L., Riggs, K. W. & Rurak, D. W. Fluoxetine during pregnancy: impact on fetal development. Reprod. Fertil. Dev. 17, 641\u2013650 (2005).","journal-title":"Reprod. Fertil. Dev."},{"key":"309_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0034-5687(94)00113-E","volume":"100","author":"TJ Moss","year":"1995","unstructured":"Moss, T. J., Jakubowska, A. E., McCrabb, G. J., Billings, K. & Harding, R. Ventilatory responses to progressive hypoxia and hypercapnia in developing sheep. Respir. Physiol. 100, 33\u201344 (1995).","journal-title":"Respir. Physiol."},{"key":"309_CR9","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1071\/RD07149","volume":"20","author":"DW Rurak","year":"2008","unstructured":"Rurak, D. W., Fay, S. & Gruber, N. C. Measurement of rest and activity in newborn lambs using actigraphy: studies in term and preterm lambs. Reprod. Fertil. Dev. 20, 418\u2013430 (2008).","journal-title":"Reprod. Fertil. Dev."},{"key":"309_CR10","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jchromb.2010.12.020","volume":"879","author":"TW Chow","year":"2011","unstructured":"Chow, T. W., Szeitz, A., Rurak, D. W. & Riggs, K. W. A validated enantioselective assay for the simultaneous quantitation of (R)-, (S)-fluoxetine and (R)-, (S)-norfluoxetine in ovine plasma using liquid chromatography with tandem mass spectrometry (LC\/MS\/MS). J. Chromatogr. B 879, 349\u2013358 (2011).","journal-title":"J. Chromatogr. B"},{"key":"309_CR11","unstructured":"Altman, D. Some common problems in medical research. In: Practical Statistics for Medical Research. London: Chapman & Hall. (pp. 426\u2013439). (1991)."},{"key":"309_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1365-2125.2005.02538.x","volume":"61","author":"J Kim","year":"2006","unstructured":"Kim, J. et al. Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feeding. Br. J. Clin. Pharmacol. 61, 155\u2013163 (2006).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"309_CR13","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1124\/dmd.32.2.212","volume":"32","author":"J Kim","year":"2004","unstructured":"Kim, J., Riggs, K. W. & Rurak, D. W. Stereoselective pharmacokinetics of fluoxetine and norfluoxetine enantiomers in pregnant sheep. Drug Metab. Dispos. 32, 212\u2013221 (2004).","journal-title":"Drug Metab. Dispos."},{"key":"309_CR14","first-page":"1044","volume":"297","author":"BJ Ring","year":"2001","unstructured":"Ring, B. J. et al. Identification of the human cytochromes p450 responsible for in vitro formation of R- and S-norfluoxetine. J. Pharmacol. Exp. Ther. 297, 1044\u20131050 (2001).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"309_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1177\/00912700022008702","volume":"40","author":"CL Alfaro","year":"2000","unstructured":"Alfaro, C. L., Lam, Y. W., Simpson, J. & Ereshefsky, L. CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: intraindividual variability and plasma concentration correlations. J. Clin. Pharmacol. 40, 58\u201366 (2000).","journal-title":"J. Clin. Pharmacol."},{"key":"309_CR16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1017\/S1461145704004286","volume":"7","author":"J Rampono","year":"2004","unstructured":"Rampono, J., Proud, S., Hackett, L. P., Kristensen, J. H. & Ilett, K. F. A pilot study of newer antidepressant concentrations in cord and maternal serum and possible effects in the neonate. Int. J. Neuropsychopharmacol. 7, 329\u2013334 (2004).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"309_CR17","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1542\/peds.92.5.721","volume":"92","author":"MJ Spencer","year":"1993","unstructured":"Spencer, M. J. Fluoxetine hydrochloride (Prozac) toxicity in a neonate. Pediatrics 92, 721\u2013722 (1993).","journal-title":"Pediatrics"},{"key":"309_CR18","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1071\/RD09156","volume":"22","author":"NW Bessette","year":"2010","unstructured":"Bessette, N. W. & Rurak, D. W. Chronic fetal and maternal instrumentation in pregnant sheep: effect on gestation length and birthweight. Reprod. Fertil. Dev. 22, 459\u2013467 (2010).","journal-title":"Reprod. Fertil. Dev."},{"key":"309_CR19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1203\/PDR.0b013e31821ba11a","volume":"70","author":"D Rurak","year":"2011","unstructured":"Rurak, D. et al. Third trimester fetal heart rate and Doppler middle cerebral artery blood flow velocity characteristics during prenatal selective serotonin reuptake inhibitor exposure. Pediatr. Res. 70, 96\u2013101 (2011).","journal-title":"Pediatr. Res."},{"key":"309_CR20","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.theriogenology.2004.06.003","volume":"63","author":"CM Dwyer","year":"2005","unstructured":"Dwyer, C. M., Calvert, S. K., Farish, M., Donbavand, J. & Pickup, H. E. Breed, litter and parity effects on placental weight and placentome number, and consequences for the neonatal behaviour of the lamb. Theriogenology 63, 1092\u20131110 (2005).","journal-title":"Theriogenology"},{"key":"309_CR21","doi-asserted-by":"publisher","first-page":"e600","DOI":"10.1542\/peds.2008-3655","volume":"125","author":"LH Pedersen","year":"2010","unstructured":"Pedersen, L. H., Henriksen, T. B. & Olsen, J. Fetal exposure to antidepressants and normal milestone development at 6 and 19 months of age. Pediatrics 125, e600\u2013e608 (2010).","journal-title":"Pediatrics"},{"key":"309_CR22","unstructured":"Nguyen, T. T. Cardiovascular, metabolic, endocrine and behavioral aspects of development in postnatal lambs in relation to acute fluoxetine administration. PhD Thesis, University of British Columbia ( https:\/\/open.library.ubc.ca\/cIRcle\/collections\/ubctheses\/24\/items\/1.0073940 ) (2013)."},{"key":"309_CR23","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1542\/peds.113.2.368","volume":"113","author":"PS Zeskind","year":"2004","unstructured":"Zeskind, P. S. & Stephens, L. E. Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics 113, 368\u2013375 (2004).","journal-title":"Pediatrics"},{"key":"309_CR24","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1542\/peds.104.5.e61","volume":"104","author":"CD Chambers","year":"1999","unstructured":"Chambers, C. D. et al. Weight gain in infants breastfed by mothers who take fluoxetine. Pediatrics 104, e61 (1999).","journal-title":"Pediatrics"},{"key":"309_CR25","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1203\/00006450-200204000-00007","volume":"51","author":"JL Morrison","year":"2002","unstructured":"Morrison, J. L., Chien, C., Riggs, K. W., Gruber, N. & Rurak, D. Effect of maternal fluoxetine administration on uterine blood flow, fetal blood gas status and growth. Pedia. Res 51, 433\u2013442 (2002).","journal-title":"Pedia. Res"},{"key":"309_CR26","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1203\/PDR.0b013e318193594a","volume":"65","author":"S Davidson","year":"2009","unstructured":"Davidson, S. et al. Effect of exposure to selective serotonin reuptake inhibitors in utero on fetal growth: potential role for the IGF-I and HPA axes. Pediatr. Res. 65, 236\u2013241 (2009).","journal-title":"Pediatr. Res."},{"key":"309_CR27","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/j.1476-5381.1992.tb09082.x","volume":"105","author":"J Ortiz","year":"1992","unstructured":"Ortiz, J. & Artigas, F. Effects of monoamine uptake inhibitors on extracellular and platelet 5-hydroxytryptamine in rat blood: different effects of clomipramine and fluoxetine. Br. J. Pharmacol. 105, 941\u2013946 (1992).","journal-title":"Br. J. Pharmacol."},{"key":"309_CR28","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1160\/TH03-05-0330","volume":"91","author":"E Maurer-Spurej","year":"2004","unstructured":"Maurer-Spurej, E., Pittendreigh, C. & Solomons, K. The influence of selective serotonin reuptake inhibitors on human platelet serotonin. Thromb. Haemost. 91, 119\u2013128 (2004).","journal-title":"Thromb. Haemost."},{"key":"309_CR29","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1053\/cp.1999.v66.103402001","volume":"66","author":"JC Alvarez","year":"1999","unstructured":"Alvarez, J. C. et al. Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine. Clin. Pharmacol. Ther. 66, 617\u2013624 (1999).","journal-title":"Clin. Pharmacol. Ther."},{"key":"309_CR30","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/j.1440-1681.1987.tb01874.x","volume":"14","author":"M Nelson","year":"1987","unstructured":"Nelson, M. et al. Ritanserin and serotonergic mechanisms in blood pressure and fluid regulation in sheep. Clin. Exp. Pharmacol. Physiol. 14, 555\u2013563 (1987).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"309_CR31","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1755-5922.2010.00173.x","volume":"29","author":"SW Watts","year":"2011","unstructured":"Watts, S. W. & Davis, R. P. 5-Hydroxtryptamine receptors in systemic hypertension: an arterial focus. Cardiovasc. Ther. 29, 54\u201367 (2011).","journal-title":"Cardiovasc. Ther."},{"key":"309_CR32","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/BF02344729","volume":"43","author":"S Lange","year":"2005","unstructured":"Lange, S., Van Leeuwen, P., Geue, D., Hatzmann, W. & Gronemeyer, D. Influence of gestational age, heart rate, gender and time of day on fetal heart rate variability. Med. Biol. Eng. Comput. 43, 481\u2013486 (2005).","journal-title":"Med. Biol. Eng. Comput."},{"key":"309_CR33","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s002469900178","volume":"18","author":"M Massin","year":"1997","unstructured":"Massin, M. & von Bernuth, G. Normal ranges of heart rate variability during infancy and childhood. Pediatr. Cardiol. 18, 297\u2013302 (1997).","journal-title":"Pediatr. Cardiol."},{"key":"309_CR34","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.earlhumdev.2008.06.008","volume":"84","author":"TF Oberlander","year":"2008","unstructured":"Oberlander, T. F. et al. Hypothalamic-pituitary-adrenal (HPA) axis function in 3-month old infants with prenatal selective serotonin reuptake inhibitor (SSRI) antidepressant exposure. Early Hum. Dev. 84, 689\u2013697 (2008).","journal-title":"Early Hum. Dev."},{"key":"309_CR35","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/S0024-3205(99)00169-1","volume":"65","author":"DK Raap","year":"1999","unstructured":"Raap, D. K., Van & de Kar, L. D. Selective serotonin reuptake inhibitors and neuroendocrine function. Life. Sci. 65, 1217\u20131235 (1999).","journal-title":"Life. Sci."},{"key":"309_CR36","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.pnpbp.2005.04.026","volume":"29","author":"ME Jongsma","year":"2005","unstructured":"Jongsma, M. E., Bosker, F. J., Cremers, T. I., Westerink, B. H. & den Boer, J. A. The effect of chronic selective serotonin reuptake inhibitor treatment on serotonin 1B receptor sensitivity and HPA axis activity. Prog. Neuropsychopharmacol. Biol. Psychiatry 29, 738\u2013744 (2005).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"309_CR37","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1038\/npp.2011.67","volume":"36","author":"EJ Mulder","year":"2011","unstructured":"Mulder, E. J., Ververs, F. F., de Heus, R. & Visser, G. H. Selective serotonin reuptake inhibitors affect neurobehavioral development in the human fetus. Neuropsychopharmacology 36, 1961\u20131971 (2011).","journal-title":"Neuropsychopharmacology"},{"key":"309_CR38","doi-asserted-by":"publisher","first-page":"e0154628","DOI":"10.1371\/journal.pone.0154628","volume":"11","author":"J Kivisto","year":"2016","unstructured":"Kivisto, J., Lehto, S. M., Halonen, K., Georgiadis, L. & Heinonen, S. Maternal use of selective serotonin reuptake inhibitors and lengthening of the umbilical cord: indirect evidence of increased foetal activity\u2014a retrospective cohort study. PLoS ONE 11, e0154628 (2016).","journal-title":"PLoS ONE"},{"key":"309_CR39","doi-asserted-by":"publisher","first-page":"e662","DOI":"10.1542\/peds.2009-0442","volume":"124","author":"JL Pawluski","year":"2009","unstructured":"Pawluski, J. L., Galea, L. A., Brain, U., Papsdorf, M. & Oberlander, T. F. Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors. Pediatrics 124, e662\u2013e670 (2009).","journal-title":"Pediatrics"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41390-019-0309-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41390-019-0309-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41390-019-0309-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:25:28Z","timestamp":1684617928000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-019-0309-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,9]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["309"],"URL":"https:\/\/doi.org\/10.1038\/s41390-019-0309-8","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,9]]},"assertion":[{"value":"2 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}